All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

GLP-1 self-criticism videos and what the science says about shame-based weight narratives

Shanna_Beth

TikTok creator

23.7K viewsWatch on TikTok→

Quick answer

Shanna is experiencing hair loss on tirzepatide and attributing it primarily to not taking vitamins, while reporting adequate dietary protein and fiber intake. Telogen effluvium secondary to rapid weight loss is the most likely clinical explanation, with nutritional deficiencies as a contributing but secondary factor. Patients on GLP-1 medications should be counseled at initiation about expected temporary hair shedding and protein optimization strategies, rather than learning about it from self-blame TikTok follow-ups.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.

What did @shanna_beth actually say?

She's blaming herself. Shanna posted a follow-up about hair loss while on tirzepatide, and her explanation was simple: "I don't take vitamins. I know that I'm awful." She says her diet is solid, she's getting protein and fiber, but she just can't stick to supplements. She also clarified she buys her own products and doesn't earn commission. That's the whole claim: hair loss is her fault because she skips her vitamins.

She's not making a medical argument here. She's offering a personal theory. And to be fair to her, she's not pretending to have answers. But when 23,000 people watch you explain why you're losing hair on a GLP-1, the personal theory becomes a de facto health message whether you intended it that way or not.

Does the science back this up?

Partially, but the vitamin angle is being given way too much credit. Hair loss on GLP-1 medications is real, documented, and mostly driven by rapid weight loss, not nutrient gaps alone. The clinical term is telogen effluvium, and it's a stress response where hair follicles prematurely shift into a resting phase.

A 2023 analysis of the SURMOUNT-1 trial data (Jastreboff et al., NEJM, 2022) noted hair loss as an adverse event in roughly 5-6% of tirzepatide participants at higher doses. That's not a vitamin deficiency number. That's a physiological response to caloric restriction and metabolic change. Studies on bariatric surgery patients, who experience similar rapid weight loss, consistently show telogen effluvium even when nutritional status is optimized (Mechanick et al., Obesity, 2013). Zinc, biotin, iron, and protein deficiency can all worsen hair loss, so supplements aren't irrelevant. But they're not the primary cause either.

What did they get wrong (or right)?

She got one thing right: nutritional intake genuinely matters for hair health on GLP-1s. Protein especially. When appetite suppression cuts calories dramatically, hitting adequate protein becomes harder, and that does accelerate shedding. Her point that she prioritizes protein and fiber is actually the correct instinct.

What she got wrong, or at least oversimplified, is framing this entirely as personal failure. "It's my own fault" suggests that if she just took her vitamins, the hair loss would stop. The evidence doesn't support that. Telogen effluvium from rapid weight loss typically resolves on its own within 3-6 months as the body adapts, regardless of supplementation (Phillips, Journal of the American Academy of Dermatology, 1997). Vitamins may reduce severity, but they are unlikely to be the root cause or the cure here.

She also mentions buying from "omega aminos" and "happy peptides" and "mindful research." These appear to be compounded peptide suppliers. No endorsement of those sources is warranted here, and sourcing compounded peptides outside a licensed medical provider is a significant regulatory and safety concern worth flagging.

What should you actually know?

Hair loss on tirzepatide or semaglutide is common, and it is not a character flaw. The mechanism is almost certainly telogen effluvium triggered by caloric deficit and metabolic stress, not a vitamin cabinet you forgot to open. That said, nutritional support is not useless: iron, zinc, and adequate protein have evidence behind them for hair health, and GLP-1 users who are eating less need to be intentional about hitting protein targets.

The practical guidance from most obesity medicine clinicians is to aim for 1.2-1.5 grams of protein per kilogram of body weight, prioritize iron and zinc from food or supplementation, and understand that shedding often peaks around month 2-4 and then improves. If hair loss is severe or prolonged, a dermatologist or your prescribing provider should evaluate for other causes like thyroid dysfunction or iron-deficiency anemia, both of which are worth ruling out.

  • Telogen effluvium is a documented side effect of GLP-1 medications, not just a supplement compliance problem.
  • Blaming yourself for a known pharmacological side effect is both inaccurate and discouraging.
  • Sourcing any compounded medication outside a licensed telehealth or clinical provider carries real safety and legal risks.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

GLP-1 social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 6 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For GLP-1 self-criticism videos and what the science says about shame-based weight narratives, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

GLP-1 self-criticism videos and what the science says about shame-based weight narratives is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

Compare providers, services and access requirements in the directory before contacting a suitable care team.

Claim verdict

The useful answer behind this video

Claim being checked

Shanna is experiencing hair loss on tirzepatide and attributing it primarily to not taking vitamins, while reporting adequate dietary protein and fiber intake.

FormBlends verdict

Shanna is experiencing hair loss on tirzepatide and attributing it primarily to not taking vitamins, while reporting adequate dietary protein and fiber intake. Telogen effluvium secondary to rapid weight loss is the most likely clinical explanation, with nutritional deficiencies as a contributing but secondary factor. Patients on GLP-1 medications should be counseled at initiation about expected temporary hair shedding and protein optimization strategies, rather than learning about it from self-blame TikTok follow-ups.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • Shanna is experiencing hair loss on tirzepatide and attributing it primarily to not taking vitamins, while reporting adequate dietary protein and fiber intake. Telogen effluvium secondary to rapid weight loss is the most likely clinical explanation, with nutritional deficiencies as a contributing but secondary factor. Patients on GLP-1 medications should be counseled at initiation about expected temporary hair shedding and protein optimization strategies, rather than learning about it from self-blame TikTok follow-ups.
  • Telogen effluvium affects roughly 5-6% of tirzepatide users at higher doses per SURMOUNT-1 trial data (Jastreboff et al., NEJM, 2022), and is triggered by caloric restriction, not just vitamin gaps.
  • Hair shedding from rapid weight loss typically peaks at months 2-4 and resolves within 3-6 months as the body adapts, with or without supplementation (Phillips, JAAD, 1997).

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • Telogen effluvium affects roughly 5-6% of tirzepatide users at higher doses per SURMOUNT-1 trial data (Jastreboff et al., NEJM, 2022), and is triggered by caloric restriction, not just vitamin gaps.
  • Hair shedding from rapid weight loss typically peaks at months 2-4 and resolves within 3-6 months as the body adapts, with or without supplementation (Phillips, JAAD, 1997).
  • Protein intake of 1.2-1.5g per kilogram of body weight is the standard recommendation for GLP-1 patients to minimize muscle and hair loss during active weight loss.
  • Iron, zinc, and biotin deficiency can contribute to worsening hair loss, so targeted supplementation is reasonable, but it is unlikely to eliminate GLP-1-related shedding entirely.
  • Sourcing compounded tirzepatide or semaglutide from unregulated online vendors bypasses FDA oversight and introduces unknown purity, dosing, and sterility risks.
  • Self-blame for a documented pharmacological side effect may discourage patients from reporting symptoms to their prescriber, which delays appropriate clinical evaluation.
  • Thyroid dysfunction and iron-deficiency anemia can also cause hair loss and should be ruled out by a provider before attributing shedding solely to GLP-1 use or supplement habits.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Shanna_Beth · TikTok creator

23.7K views on this video

I suck. I know lol

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by Shanna_Beth, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.